Deferasirox 125 mg / 1 Tablet 30 Tablet, For Suspension

Reference details for licensed healthcare facility review and verification.

Deferasirox NDC Family 00480-7011 Deferasirox 125 mg / 1

NDC 11	00480-7011-56
Product NDC	00480-7011
Generic Drug Name	Deferasirox
Brand Name	Deferasirox
Manufacturer	Teva Pharmaceuticals, Inc.
Strength	125 mg / 1
Dosage Form	Tablet
Drug Type	Oral
Package Quantity	30 Tablet, For Suspension
Package Description	30 TABLET, FOR SUSPENSION in 1 BOTTLE (0480-7011-56)
Active Ingredients	Deferasirox
Marketing Category	ANDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this exact presentation or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other exact NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

Deferasirox 125 mg / 1 Tablet is tracked under NDC 00480-7011-56 and rolls up into product family 00480-7011. Use this page to confirm the exact presentation before comparing related family pages or starting a quote review.

Package configuration: 30 Tablet, For Suspension.
Manufacturer: Teva Pharmaceuticals, Inc..
Dosage form: Tablet.
Family size: 1 indexed presentation.

Click a tag to refine the catalog view around this exact presentation.

Review the generic familyDeferasirox

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Potential alternatives with matching presentation

Open the comparison hub or review exact-item pages from 10 product-NDC families with matching normalized presentation details. Review each exact page before treating any item as a true alternative.

Deferasirox 125 mg / 1 Tablet 30 Tablet, For Suspension, NDC 00480-7011-56, is a Teva Pharmaceuticals, Inc. 125 mg / 1 tablet presentation packaged as 30 Tablet, For Suspension.

NDC search formats

Canonical NDC 11: 00480-7011-56
Digits-only NDC 11: 00480701156
Possible 10-digit display format: 0480-7011-56 (0480701156)

Helpful product links

Search by brand name: Deferasirox
Exact NDC 11: 00480-7011-56
Product family NDC: 00480-7011
VA classification code: AD300
VA classification code description: HEAVY METAL ANTAGONISTS
CMOP ID: D1230
VUID: 4038963